From: Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis
Hub genes/clinical traits | Univariate logistic regression | Multivariate logistic regression | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | |
Gender | 1.578 | 0.218, 7.618 | 0.929 | Â | Â | Â |
Age | 0.943 | 0.878, 1.013 | 0.108 | Â | Â | Â |
Course of disease | 0.991 | 0.898, 1.093 | 0.857 | Â | Â | Â |
Raynaud’s phenomenon | 0.421 | 0.050, 3.532 | 0.425 |  |  |  |
Anti-Scl-70 antibody (+) | 2.121 | 0.428, 10.515 | 0.357 | Â | Â | Â |
ANA (+) | 0.970 | 0.982, 1.0010 | 0.834 | Â | Â | Â |
Anti-RNP (+) | 0.353 | 0.066, 1.874 | 0.221 | Â | Â | Â |
Anti-centromere (+) | 4.500 | 0.471, 42.970 | 0.191 | Â | Â | Â |
mRSS | 0.876 | 0.770, 0.997 | 0.044* | 0.917 | 0.807, 1.042 | 0.184 |
FVC (%predict) | 1.003 | 0.973, 1.033 | 0.865 | Â | Â | Â |
DLCO (%predict) | 1.071 | 0.934, 1.228 | 0.325 | Â | Â | Â |
FEV1/FVC% | 1.087 | 0.944, 1.253 | 0.245 | Â | Â | Â |
ESR, mm/h | 0.991 | 0.925, 1.062 | 0.800 | Â | Â | Â |
PLT, 109/L | 0.999 | 0.987, 1.010 | 0.850 | Â | Â | Â |
MPV, fL | 0.829 | 0.503, 1.365 | 0.461 | Â | Â | Â |
PDW, fL | 0.282 | 0.000, 21.236 | 0.825 | Â | Â | Â |
PCT, % | 0.959 | 0.895, 1.028 | 0.235 | Â | Â | Â |
P-LCR, % | 0.916 | 0.730, 1.149 | 0.449 | Â | Â | Â |
Calpain activity | 1.057 | 1.002, 1.115 | 0.041* | 1.063 | 0.968, 1.166 | 0.202 |
HMGB1 | 1.190 | 1.006, 1.408 | 0.043* | 1.414 | 0.953, 2.096 | 0.085 |